Works matching IS 01145916 AND DT 2025 AND VI 48 AND IP 6

Results: 9

Pregnancy and Infant Outcomes in Women with Multiple Sclerosis Exposed to Glatiramer Acetate Therapy: An Extended 4-Year Safety Update.

Published in:

Drug Safety, 2025, v. 48, n. 6, p. 697, doi. 10.1007/s40264-025-01523-y

By:

Kaplan, Sigal;
Ghimpeteanu, Andra;
Dragut, Claudia Florentina

Publication type:

Article

Pharmacogenetic Testing in the Outpatient Setting in Switzerland: A Descriptive Study Using Swiss Claims Data.

Published in:

Drug Safety, 2025, v. 48, n. 6, p. 689, doi. 10.1007/s40264-025-01522-z

By:

Wittwer, Nina L.;
Meier, Christoph R.;
Huber, Carola A.;
Meyer zu Schwabedissen, Henriette E.;
Allemann, Samuel;
Schneider, Cornelia

Publication type:

Article

Delphi Method Consensus on Statistical Analysis and Reporting Recommendations for Single-Arm Pregnancy Medication Safety Studies Investigating Pregnancy, Birth and Neonatal Health Outcomes: A Contribution from IMI-ConcePTION.

Published in:

Drug Safety, 2025, v. 48, n. 6, p. 643, doi. 10.1007/s40264-025-01521-0

By:

Richardson, Jonathan L.;
Moore, Alan;
Stellfeld, Michael;
Geissbühler, Yvonne;
Winterfeld, Ursula;
Favre, Guillaume;
Chambers, Christina;
Beck, Evelin;
Onken, Marlies;
Dathe, Katarina;
Ceulemans, Michael;
Diav-Citrin, Orna;
Shechtman, Svetlana;
Oliver, Alison M.;
Hodson, Kenneth K.;
Shiller, Dee-Dee;
Alexe, Amalia;
van Puijenbroek, Eugène P.;
Lewis, David J.;
Yates, Laura M.

Publication type:

Article

Navigating Diverging Perspectives: Reasoning, Evidence, and Decision-Making in Drug Safety.

Published in:

Drug Safety, 2025, v. 48, n. 6, p. 587, doi. 10.1007/s40264-025-01537-6

By:

Hammad, Tarek A.;
Davies, Simon

Publication type:

Article

Evidence-Based Design of Prescription Medication Information: An Updated Scoping Review.

Published in:

Drug Safety, 2025, v. 48, n. 6, p. 607, doi. 10.1007/s40264-025-01527-8

By:

Russell, Andrea M.;
Lovett, Rebecca;
Vogeley, Abigail;
Nunes, Denise A.;
McKelvie, Carolyn;
Middleton, Wayne;
Wolf, Michael

Publication type:

Article

Effectiveness of Transformer-Based Large Language Models in Identifying Adverse Drug Reaction Relations from Unstructured Discharge Summaries in Singapore.

Published in:

Drug Safety, 2025, v. 48, n. 6, p. 667, doi. 10.1007/s40264-025-01525-w

By:

Koon, Yen Ling;
Lam, Yan Tung;
Tan, Hui Xing;
Teo, Desmond Hwee Chun;
Neo, Jing Wei;
Yap, Aaron Jun Yi;
Ang, Pei San;
Loke, Celine Ping Wei;
Tham, Mun Yee;
Tan, Siew Har;
Soh, Sally Leng Bee;
Foo, Belinda Qin Pei;
Ling, Zheng Jye;
Yip, James Luen Wei;
Dorajoo, Sreemanee Raaj

Publication type:

Article

Are Causal Statements Reported in Pharmacovigilance Disproportionality Analyses Using Individual Case Safety Reports Exaggerated in Related Citations? A Meta-epidemiological Study.

Published in:

Drug Safety, 2025, v. 48, n. 6, p. 679, doi. 10.1007/s40264-025-01524-x

By:

Bernardeau, Claire;
Revol, Bruno;
Salvo, Francesco;
Fusaroli, Michele;
Raschi, Emanuel;
Cracowski, Jean-Luc;
Roustit, Matthieu;
Khouri, Charles

Publication type:

Article

Leveraging FDA Labeling Documents and Large Language Model to Enhance Annotation, Profiling, and Classification of Drug Adverse Events with AskFDALabel.

Published in:

Drug Safety, 2025, v. 48, n. 6, p. 655, doi. 10.1007/s40264-025-01520-1

By:

Wu, Leihong;
Fang, Hong;
Qu, Yanyan;
Xu, Joshua;
Tong, Weida

Publication type:

Article

Aggregation of Adverse Event Terms for Signal Detection and Labeling in Clinical Trials.

Published in:

Drug Safety, 2025, v. 48, n. 6, p. 595, doi. 10.1007/s40264-025-01518-9

By:

Zink, Richard C.;
Lyzinski, Rebecca;
Mann, Geoffrey

Publication type:

Article